My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
April 2016
PATIENT CARE AND SCIENCE
Lyme Disease Guideline Panel Responds to Public Comments
IDSA, the American Academy of Neurology (AAN) and the American College of Rheumatology (ACR) are jointly developing a systematic review and clinical practice guideline on treatment of Lyme disease. 
 
The guideline panel held a public comment period last spring requesting input on a project plan that laid the ground work for the new Lyme disease guideline. The panel has published its response (PDF) to input received during the public comment period.
 
In addition to representatives from IDSA, AAN, and ACR, the panel also includes representation from the American Academy of Family Physicians (AAFP), American Academy of Pediatrics – Committee on Infectious Diseases (AAP-COID), American Academy of Pediatrics – Section on Emergency Medicine (AAP-EM), American College of Physicians (ACP), Association of Medical Microbiology and Infectious Diseases – Canada (AMMI-CA), Child Neurology Society (CNS), Pediatric Infectious Diseases Society (PIDS), Entomological Society of America (ESA), and European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Members representing the disciplines of cardiology, microbiology, pathology, and a methodologist with expertise in GRADE are also included. In addition, the panel includes a healthcare consumer representative, three patients with confirmed Lyme disease, and a parent of a pediatric patient with confirmed Lyme disease. 
 
After a draft of the full guideline is developed, it will also be posted on the IDSA website for a 45-day public comment period. Additional information on the timing and availability of this draft will be posted to the IDSA website.
 


Next Article >

Post a comment

Your name:

Your comment:


PATIENT CARE AND SCIENCE
Lyme Disease Guideline Panel Responds to Public Comments
What ID Researchers Should Know About PCORI Funding
National Academies Seeks to End Transmission of Hepatitis B and C in US
CLINICAL PRACTICE MANAGEMENT
Now’s the Time to Double-Check CMS’s Data on You
Have a Question About Billing and Coding? Ask the Coder Can Help!
CMS Waives Certain Restrictions for Telehealth Services
New Resource Guide for HIV/AIDS Care Providers on Billing and Reimbursement
POLICY AND ADVOCACY
IDSA, HIVMA Advocate for Funding for Antimicrobial Resistance, HIV, Other ID Programs
Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria Issues Assessment of National Action Plan
Senate Committee Advances New Antibiotic Pathway and other ID Bills
Ryan White Care Providers Take to the Hill
HIVMA Hails the First U.S. HIV+ to HIV+ Organ Transplant
GLOBAL ID
IDSA’s Continued Work on Zika Virus
Science Speaks Reports a Range of Developments in Global Infectious Diseases
EDUCATION AND RESOURCES
New ABIM Survey Indicates Physician Interest in Potential Changes to MOC Assessment
ABIM Seeks Physician Input into Open Book Assessments
YOU AND YOUR COLLEAGUES
Journal Club Seeks Additional Members
Polish-Speaking Member Needed for Translation Assistance
Members on the Move
Member Report
FROM THE PRESIDENT
From the President: Christopher D. Busky, CAE Named Next CEO of IDSA
TOP STORIES
IDSA and SHEA Release New Guideline on Antibiotic Stewardship
IDSA Adopts All-In Match Policy
IDWeek Mentorship Program
Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.